Revive Therapeutics announces extension of proposed private placement

4 hours ago 1

Comments

Revive Therapeutics (OTCQB:RVVTF) announced that it was extending its previously announced private placement offering of up to 30,952,381 units, for $0.021 per unit, for gross proceeds to Revive of up to $650,000.
Revive closed a first tranche of the private placement in early August 2025 by issuing 2,900,000 units of the company at $0.021 per unit, for total gross proceeds to Revive of $60,900.
Accordingly, the company may close an additional $589,000 worth of units pursuant to the private placement.

More on Revive Therapeutics

Financial information for Revive Therapeutics

Recommended For You

More Trending News

Read Entire Article